Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-390 vs Viread in Chronic Hepatitis B
NCT02805738Phase 3Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Apr 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir disoproxil aspartate in Chronic Hepatitis B (CHB), sponsored by Chong Kun Dang Holdings. Status: unknown.
02
Drugs
tenofovir disoproxil aspartate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02805738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805738.